The study is the first to assess the argon-plasma coagulation ArC Smart linear beam for mucosal ablation in transoral outlet reduction for weight regain after Roux-en-Y gastric bypass. The noncontact design of the linear beam can enhance tissue healing and remodeling of gastrojejunal anastomosis by causing a uniform scarring with minimal tissue injury. We followed patients for 45 days, during which none experienced gastrointestinal bleeding, stenosis, or ulcers, reporting 9.8% average of total body weight loss. The ArC Smart beam may offer a safer, more effective alternative to traditional argon-plasma coagulation for transoral outlet reduction, with better reduction in weight loss, although comparative studies are needed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884829PMC
http://dx.doi.org/10.14309/crj.0000000000001631DOI Listing

Publication Analysis

Top Keywords

transoral outlet
12
outlet reduction
12
ablation transoral
8
argon-plasma coagulation
8
arc smart
8
linear beam
8
reduction weight
8
weight loss
8
tissue remodeling
4
remodeling homogenous
4

Similar Publications

The study is the first to assess the argon-plasma coagulation ArC Smart linear beam for mucosal ablation in transoral outlet reduction for weight regain after Roux-en-Y gastric bypass. The noncontact design of the linear beam can enhance tissue healing and remodeling of gastrojejunal anastomosis by causing a uniform scarring with minimal tissue injury. We followed patients for 45 days, during which none experienced gastrointestinal bleeding, stenosis, or ulcers, reporting 9.

View Article and Find Full Text PDF

Strategies to Manage Obesity: Endoscopic Bariatric and Metabolic Therapies.

Methodist Debakey Cardiovasc J

February 2025

Underwood Center for Digestive Disorders, Houston Methodist Hospital, Houston, Texas, US.

Over the past two decades, numerous endoscopic bariatric and metabolic therapies (EBMTs) have been developed with the goal of providing additional effective and safe tools for the treatment of obesity. These treatments are an ultra-minimally invasive option for patients with class I, class II, and class III obesity. Many of these EBMTs can be utilized as primary therapies for treatment-naïve patients or as a treatment for weight regain after bariatric surgery.

View Article and Find Full Text PDF

Background: Transoral outlet reduction endoscopy (TORe) and glucagon-like peptide-1 agonist, liraglutide, have individually shown promise in managing weight regain after Roux-en-Y gastric bypass. However, combined effects of adjunctive liraglutide to TORe remain unexplored. A cross-over design was utilized to evaluate the efficacy of liraglutide treatment when initiated immediately post-TORe or 1 year post-TORe.

View Article and Find Full Text PDF

Top TIPS for Transoral Outlet Reduction.

Gastrointest Endosc

January 2025

Division of Gastroenterology and Hepatology, Heersink School of Medicine, The University of Alabama at Birmingham, AL 35205. Electronic address:

View Article and Find Full Text PDF

Current State of Endoscopic Bariatric Therapies.

Surg Clin North Am

February 2025

Department of Surgery, Yale School of Medicine, PO Box 208062, New Haven, CT 06520, USA. Electronic address:

The obesity epidemic poses a significant global health challenge. Despite proven efficacy, accessibility to bariatric surgery is limited. Endoscopic bariatric therapies offer less invasive alternatives.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!